Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance

by J.X. Hing, C.W. Mok, P.T. Tan, S.S. Sudhakar, C.M. Seah, W.P. Lee, S.M. Tan
Published 2020-08-01